Human decellularized adipose tissue scaffold as a model for breast cancer cell growth and drug treatments

Biomaterials

Volumn 35, Issue 18, 2014, Pages 4940-4949

  Dunne, Lina W ^a   Huang, Zhao ^b   Meng, Weixu ^b   Fan, Xuejun ^b   Zhang, Ningyan ^b   Zhang, Qixu ^a   An, Zhiqiang ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adipose extracellular matrix; Breast cancer; Cancer therapeutics; Tumor microenvironment

Indexed keywords

BIOMIMETICS; CELL CULTURE; CELL PROLIFERATION; CELLS; DIAGNOSIS; DISEASES; DRUG THERAPY; MORPHOLOGY; TISSUE;

ADIPOSE EXTRACELLULAR MATRIXES; BREAST CANCER; CANCER THERAPEUTICS; EXTRACELLULAR MATRICES; HUMAN ADIPOSE TISSUE; THREE-DIMENSIONAL CULTURE; TUMOR MICROENVIRONMENT; TWO-DIMENSIONAL SURFACE;

SCAFFOLDS (BIOLOGY);

CELL ADHESION MOLECULE; DOXORUBICIN; HUMAN DECELLULARIZED ADIPOSE TISSUE SCAFFOLD; LAPATINIB; MATRIGEL; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; QUINAZOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMIMETICS; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REGENERATION; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ADIPOSE TISSUE; ANIMAL; BAGG ALBINO MOUSE; BREAST NEOPLASMS; CANCER TRANSPLANTATION; CELL ADHESION; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; MCF 7 CELL LINE; METABOLISM; NUDE MOUSE; PHYSIOLOGY; REGENERATION; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING; TISSUE SCAFFOLD; TUMOR CELL LINE;

ADIPOSE TISSUE; ANIMALS; ANTINEOPLASTIC AGENTS; BIOMIMETICS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MCF-7 CELLS; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON, SCANNING; NEOPLASM TRANSPLANTATION; QUINAZOLINES; REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84897915482     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.003     Document Type: Article

References (52)

1. Elliott N.T., Yuan F. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J Pharm Sci 2011, 100:59-74.
2. Pampaloni F., Reynaud E.G., Stelzer E.H.K. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 2007, 8:839-845.
3. Lee G.Y., Kenny P.A., Lee E.H., Bissell M.J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007, 4:359-365.
4. Kenny P.A., Lee G.Y., Myers C.A., Neve R.M., Semeiks J.R., Spellman P.T., et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007, 1:84-96.
5. Lin R.-Z., Lin R.-Z., Chang H.-Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 2008, 3:1172-1184.
6. Souza G.R., Molina J.R., Raphael R.M., Ozawa M.G., Stark D.J., Levin C.S., et al. Three-dimensional tissue culture based on magnetic cell levitation. Nat Nanotechnol 2010, 5:291-296.
7. Debnath J., Muthuswamy S.K., Brugge J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30:256-268.
8. Lu Z., Jiang G., Blume-Jensen P., Hunter T. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 2001, 21:4016-4031.
9. Oh S.K.W., Chen A.K., Mok Y., Chen X., Lim U.-M., Chin A., et al. Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res 2009, 2:219-230.
10. Wu Z.-Z., Zhao Y.-P., Kisaalita W.S. A packed Cytodex microbead array for three-dimensional cell-based biosensing. Biosens Bioelectron 2006, 22:685-693.
11. Gurski L.A., Jha A.K., Zhang C., Jia X., Farach-Carson M.C. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 2009, 30:6076-6085.
12. Burdick J.A., Anseth K.S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002, 23:4315-4323.
13. Fischbach C., Chen R., Matsumoto T., Schmelzle T., Brugge J.S., Polverini P.J., et al. Engineering tumors with 3D scaffolds. Nat Methods 2007, 4:855-860.
14. Yoshii Y., Waki A., Yoshida K., Kakezuka A., Kobayashi M., Namiki H., et al. The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation. Biomaterials 2011, 32:6052-6058.
15. Shin J.-Y., Park J., Jang H.-K., Lee T.-J., La W.-G., Bhang S.H., et al. Efficient formation of cell spheroids using polymer nanofibers. Biotechnol Lett 2012, 34:795-803.
16. Birgersdotter A., Sandberg R., Ernberg I. Gene expression perturbation in vitro-a growing case for three-dimensional (3D) culture systems. Semin Cancer Biol 2005, 15:405-412.
17. Kleinman H.K., Martin G.R. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 2005, 15:378-386.
18. Kim J.B. Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 2005, 15:365-377.
19. Bissell M.J., Kenny P.A., Radisky D.C. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 2005, 70:343-356.
20. Weigelt B., Lo A.T., Park C.C., Gray J.W., Bissell M.J. HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment. Breast Cancer Res Treat 2010, 122:35-43.
21. David L., Dulong V., Le Cerf D., Cazin L., Lamacz M., Vannier J.-P. Hyaluronan hydrogel: an appropriate three-dimensional model for evaluation of anticancer drug sensitivity. Acta Biomater 2008, 4:256-263.
22. Chitcholtan K., Sykes P.H., Evans J.J. The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer. J Transl Med 2012, 10:38.
23. Karlsson H., Fryknäs M., Larsson R., Nygren P. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. Exp Cell Res 2012, 318:1577-1585.
24. Masuda S., Izpisua Belmonte J.C. The microenvironment and resistance to personalized cancer therapy. Nat Rev Clin Oncol 2013, 10.
25. Işeri Ö.D., Kars M.D., Arpaci F., Atalay C., Pak I., Gündüz U. Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern. Biomed Pharmacother 2011, 65:40-45.
26. Fong E.L.S., Lamhamedi-Cherradi S.-E., Burdett E., Ramamoorthy V., Lazar A.J., Kasper F.K., et al. Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proc Natl Acad Sci U S A 2013, 110:6500-6505.
27. Girard Y.K., Wang C., Ravi S., Howell M.C., Mallela J., Alibrahim M., et al. A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development. PLoS One 2013, 8:e75345.
28. Gravdal K., Halvorsen O.J., Haukaas S.A., Akslen L.A. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 2007, 13:7003-7011.
29. Thiery J.P., Acloque H., Huang R.Y.J., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
30. Sarrió D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008, 68:989-997.
31. Foroni C., Broggini M., Generali D., Damia G. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 2012, 38:689-697.
32. Oliveras-Ferraros C., Corominas-Faja B., Cufí S., Vazquez-Martin A., Martin-Castillo B., Iglesias J.M., et al. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle 2012, 11:4020-4032.
33. Kling R.E., Mehrara B.J., Pusic A.L., Young V.L., Hume K.M., Crotty C.A., et al. Trends in autologous fat grafting to the breast: a national survey of the American Society of Plastic Surgeons. Plast Reconstr Surg 2013, 132:35-46.
34. Tan B.-K., Joethy J., Ong Y.-S., Ho G.-H., Pribaz J.J. Preferred use of the ipsilateral pedicled TRAM flap for immediate breast reconstruction: an illustrated approach. Aesthetic Plast Surg 2012, 36:128-133.
35. Wang L., Johnson J.A., Zhang Q., Beahm E.K. Combining decellularized human adipose tissue extracellular matrix and adipose-derived stem cells for adipose tissue engineering. Acta Biomater 2013, 9:8921-8931.
36. Young D.A., Ibrahim D.O., Hu D., Christman K.L. Injectable hydrogel scaffold from decellularized human lipoaspirate. Acta Biomater 2011, 7:1040-1049.
37. Wang L., Johnson J.A., Chang D.W., Zhang Q. Decellularized musculofascial extracellular matrix for tissue engineering. Biomaterials 2013, 34:2641-2654.
38. Wang L., Kisaalita W.S. Characterization of micropatterned nanofibrous scaffolds for neural network activity readout for high-throughput screening. J Biomed Mater Res B Appl Biomater 2010, 94:238-249.
39. Zhang R., Ma P.X. Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 1999, 44:446-455.
40. Yguerabide J., Schmidt J.A., Yguerabide E.E. Lateral mobility in membranes as detected by fluorescence recovery after photobleaching. Biophys J 1982, 40:69-75.
41. Axelrod D., Koppel D.E., Schlessinger J., Elson E., Webb W.W. Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. Biophys J 1976, 16:1055-1069.
42. Panasci L., Jean-Claude B.J., Vosilescu D., Mustafa A., Damian S., Damian Z., et al. Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate. Biochem Pharmacol 1996, 52:1097-1102.
43. Smith L., Watson M.B., O'Kane S.L., Drew P.J., Lind M.J., Cawkwell L. The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol Cancer Ther 2006, 5:2115-2120.
44. AbuHammad S., Zihlif M. Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line. Genomics 2013, 101:213-220.
45. Liu H., Lin J., Roy K. Effect of 3D scaffold and dynamic culture condition on the global gene expression profile of mouse embryonic stem cells. Biomaterials 2006, 27:5978-5989.
46. Meli L., Jordan E.T., Clark D.S., Linhardt R.J., Dordick J.S. Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems. Biomaterials 2012, 33:9087-9096.
47. Konecny G.E., Pegram M.D., Venkatesan N., Finn R., Yang G., Rahmeh M., et al. Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells. Cancer Res 2006, 66:1630-1639.
48. Cheng K., Lai Y., Kisaalita W.S. Three-dimensional polymer scaffolds for high throughput cell-based assay systems. Biomaterials 2008, 29:2802-2812.
49. Suh Y., Yoon C.-H., Kim R.-K., Lim E.-J., Oh Y.S., Hwang S.-G., et al. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene 2013, 32:4873-4882.
50. Sigurdsson V., Hilmarsdottir B., Sigmundsdottir H., Fridriksdottir A.J.R., Ringnér M., Villadsen R., et al. Endothelial induced EMT in breast epithelial cells with stem cell properties. PLoS One 2011, 6:e23833.
51. Weigelt B., Bissell M.J. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol 2008, 18:311-321.
52. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002, 2:48-58.